Filing Flows › Roivant Sciences (ROIV) › Stock forecast & fair value
Roivant Sciences (ROIV) stock forecast and price target
Roivant Sciences (ROIV) trades at $38.88. 11 analysts' median price target is $51.00 (+31%), from $41.00 to $62.00.
Roivant Sciences' latest quarter
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ROIV stock?
The median of 11 analysts' 12-month targets is $51.00, +31% from $38.88; the range is $41.00 to $62.00. The average rating is strong buy.
Does Roivant Sciences usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is ROIV stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.